BIOSENS is a Brazilian deeptech company specialized in life sciences. Our work encompasses research, development, production, and commercialization of point-of-care testing (POCT). Our biosensor-based technology represents a new frontier with the potential to transform laboratory diagnostics and healthcare.
Biosensors are analytical devices that convert biological interactions and chemical reactions into measurable data. We develop reactive strips, each embedded with a biosensor, designed for specific analyses. A widely recognized example of this technology is the glucometer, used for monitoring glucose in diabetic patients, illustrating one of the practical applications of our technology.
Our goal is to decentralize laboratory diagnostic exams with accessible solutions that positively impact health professionals, researchers, and improves the patient journey. BIOSENS combines transdisciplinary knowledge and innovation, with proprietary technology, integrating areas such as cellular biology, genetics, artificial intelligence, advanced materials, CRISPR, bionanotechnology, the Internet of Things (IoT), microfabrication, and MEMS. This integration places BIOSENS at the technological forefront, in Brazil and worldwide, merging science and technology to revolutionize healthcare, transform patient experiences, improve quality of life, and contribute to a better world.
To transform lives through science and technology, becoming a global leader in diagnostic solutions capable of revolutionizing healthcare. We aspire to simplify medical practice, supporting healthcare professionals in decision-making, enabling immediate care anywhere and at any time. We are dedicated to ensuring that every person can enjoy a healthier and more equitable future, eliminating barriers to a world where health is a priority and universal.
To revolutionize the healthcare experience by offering advanced point-of-care testing (POCT) that simplifies and democratizes access to medical care worldwide. We are committed to continuous innovation, quality, and precision, integrating emerging technologies such as molecular biology, artificial intelligence, and nanotechnology to support medical decision-making. Our mission is to promote precise, rapid, and accessible healthcare, improving quality of life and fostering a healthier and more equitable future for everyone, everywhere.
AV. Theodomiro Porto da Fonseca 3397, Sala 205, Unitec 3, CEP 93022-718, São Leopoldo, RS, Brasil.